FDA allowing at-home use of CapsoCam Plus

The FDA applied a labeling addendum for CapsoVision's CapsoCam Plus, which will allow for at-home administration of the device.

CapsoCam Plus is a small bowel capsule endoscope. The labeling addendum will allow for fully remote capsule endoscopy procedures. The change will eliminate the need for in-person interaction between physicians and patients.

CapsoCam Plus is the only capsule endoscopy system that doesn't require external equipment. The patient ingests the capsule, resumes daily activities while exam data is being captured, and returns the device eight to 12 hours later, where it will be disinfected between uses.

Physicians can use the CapsoCloud cloud-based software to review the images captured by the device.

More articles on healthcare:
Tennessee ASC introduces 2nd orthopedics robot — 5 details
ASC opens outside Boston with 4 joint owners — 4 things to know
Make your ASC's anesthesia program more efficient: 5 strategies

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers